目前环孢菌素在许多移植中心已成为第一线治疗药物。但是和一些新药常出现的情况一样,广泛的应用显露出此免疫抑制剂的毒性问题,因此要求对器官移植受者进行严格的监测。最近在纽约希朗克斯蒙蒂菲奥里医学中心召开的移植会议上, Cyclosporine has now become the first-line treatment in many transplant centers. However, as is often the case with some new drugs, the widespread use of this immunosuppressant has revealed the toxicity of this immunosuppressant and therefore requires rigorous monitoring of organ transplant recipients. At a recent transplant meeting at the Monilfiri Medical Center in New York, New York,